Efficacy and Safety of Bromfenac Ophthalmic Solution

Bausch + Lomb

Status and phase: Completed; Phase 2

Conditions: Cataract Surgery

Treatments: Drug: bromfenac ophthalmic solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT00585975

CL-S&E-0802071-P

Details and patient eligibility

About

This is a safety and efficacy study of bromfenac ophthalmic solution

Enrollment: 568 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male or female greater than or equal to 18 years of age, and scheduled for cataract surgery

Exclusion criteria

• Active corneal pathology in either eye

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

568 participants in 2 patient groups

Bromfenac Ophthalmic Solution 0.18%

Experimental group

Treatment:

Drug: bromfenac ophthalmic solution

Xibrom 0.09%

Experimental group

Treatment:

Drug: bromfenac ophthalmic solution